NCOA2 and endometrial cancer: Furthermore, SRC-2 in human endometrial cancer cells was recently shown to be essential for the normal performance of the pentose phosphate pathway in addition to maintaining cellular glycolytic capacity and oxidative phosphorylation (Szwarc et al., 2018b).